NCT02469116View on ClinicalTrials.gov

Carboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2009

Study Completion Date

March 31, 2010

Conditions
Ovarian Cancer
Interventions
DRUG

Docetaxel

DRUG

Carboplatin

DRUG

Pegylated G-CSF

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Washington University School of Medicine

OTHER